- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Nutrition and Metabolism
Volume 2012 (2012), Article ID 280286, 8 pages
Dietary Ganglioside Reduces Proinflammatory Signaling in the Intestine
14-002 Li Ka Shing Centre for Health Research Innovation, University of Alberta, Edmonton, AB, Canada T6G 2R1
2200, 10150-102 street, Dyna LIFE Diagnostics, Edmonton, AB, Canada T5J 5E2
3Division of Gastroenterology, University of Western Ontario, London, ON, Canada N6A 5A5
Received 9 August 2011; Revised 7 October 2011; Accepted 7 October 2011
Academic Editor: Phillip B. Hylemon
Copyright © 2012 John Janez Miklavcic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citations to this Article [8 citations]
The following is the list of published articles that have cited the current article.
- Jiliu Xu, Virginia Anderson, and Steven M. Schwarz, “Dietary GD3 Ganglioside Reduces the Incidence and Severity of Necrotizing Enterocolitis by Sustaining Regulatory Immune Responses,” Journal of Pediatric Gastroenterology and Nutrition, vol. 57, no. 5, pp. 550–556, 2013.
- Seok-Jo Kim, Tae-Wook Chung, Hee-Jung Choi, Un-Ho Jin, Ki-Tae Ha, Young-Choon Lee, and Cheorl-Ho Kim, “Monosialic ganglioside GM3 specifically suppresses the monocyte adhesion to endothelial cells for inflammation,” The International Journal of Biochemistry & Cell Biology, 2013.
- Yiren Wang, Yuting Cui, Fayang Cao, Yiyang Qin, Wenjing Li, and Jinghai Zhang, “Ganglioside GD1a suppresses LPS-induced pro-inflammatory cytokines in RAW264.7 macrophages by reducing MAPKs and NF-κB signaling pathways through TLR4,” International Immunopharmacology, vol. 28, no. 1, pp. 136–145, 2015.
- Yiren Wang, Yuting Cui, Fayang Cao, Yiyang Qin, Wenjing Li, and Jinghai Zhang, “Ganglioside GD1a suppresses LPS-induced pro-inflammatory cytokines in RAW264.7 macrophages by reducing MAPKs and NF-kappa B signaling pathways through,” International Immunopharmacology, vol. 28, no. 1, pp. 136–145, 2015.
- John J. Miklavcic, Tasha D. L. Hart, Gordon M. Lees, Glen K. Shoemaker, Kareena L. Schnabl, Bodil M. K. Larsen, Oliver F. Bathe, Alan B. R. Thomson, Vera C. Mazurak, and M. Tom Clandinin, “Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease,” World Journal Of Gastroenterology, vol. 21, no. 35, pp. 10080–10090, 2015.
- Bernadette Delplanque, Robert Gibson, Berthold Koletzko, Alexandre Lapillonne, and Birgitta Strandvik, “Lipid Quality in Infant Nutrition: Current Knowledge and Future Opportunities,” Journal Of Pediatric Gastroenterology And Nutrition, vol. 61, no. 1, pp. 8–17, 2015.
- Åke Nilsson, “Role of Sphingolipids in Infant Gut Health and Immunity,” The Journal of Pediatrics, vol. 173, pp. S53–S59, 2016.
- Loubna Abdel Hadi, Clara Di Vito, and Laura Riboni, “Fostering Inflammatory Bowel Disease: Sphingolipid Strategies to Join Forces,” Mediators of Inflammation, vol. 2016, pp. 1–13, 2016.